Wait, and where is our address? Also interestin
Post# of 30028
Also interesting...
Hamburg, Germany - 10 July 2012: Evotec AG (Frankfurt Stock Exchange: EVT, TecDAX) today announced that it has licensed to Janssen Pharmaceuticals, Inc. a portfolio of small molecules and biologics designed to trigger the regeneration of insulin-producing beta cells.
Cheers